$%,-$.,-0!,(!#'/-,)+0&,%*,+,)0! Prof. Akira Kurosaka, Ph. D. @ ! ! ! Assist. Prof. Yoshiaki...
Click here to load reader
Transcript of $%,-$.,-0!,(!#'/-,)+0&,%*,+,)0! Prof. Akira Kurosaka, Ph. D. @ ! ! ! Assist. Prof. Yoshiaki...
��! �! �
����������"$%,-$.,-0!,(!#'/-,)+0&,%*,+,)0!
Prof. Akira Kurosaka, Ph. D. ŀ
��! �! ��!
Assist. Prof. Yoshiaki Nakayama, Ph. D.
76����!
ŀ ÛĨƙ�&/qƚĤýƗåąk�Ĺ/qƙ�ƑƔŻ
ƩǪƌƙ�ĚƚǪżƃƑƀƙLJƳǗƘ ķƆƫƪǫwźƚ
ŞŹƱDŽLjǢƹǠƻnjƿǛǥŁŘťŭŞŒŦłǪǚǥǐǧǃǨŝťůǩǪ
ŻƪżƚǴŹƱDŽLjǢƼǢƾƿǛǥŁŘŭŦŞŒŦłƕLJǥǒƻĐ
�ƙDŽǡǥǪnjǣƷǏǥ¢HƙǓǍǤƺǁǢHƕƙīƘi
vƆƫƪ şŹƼǡƾǁǍEâ5ǨŘťŭŞŒŦαňŸŢŨŲņţūŲŃŀ
ŝťůαňŸŢŨŲņţūŲŃŀ ŘŭŦŞŒŦβňŸŢŨŲņţūŲǩƮ�ƑÛĨƘ
§ÆƇǪƌƫƨƙ�ƘëƘſƄƪ�êƮĂ�ƇƓżƪǫƅ
ƙ�Ɣ ŘťŭŞŒŦαňŸŢŨŲņţūŲ ƙÛĨƚǪÙrLJǥǒƻĐ
ƔŻƪǜLjǥƘNƃþƨƫƪƅƕƀƨǪǜLjǥEÛĨƕƤ9
ƛƫƪǫŀ
ŀ ǜ Lj ǥE Û Ĩ ƙ5vĪQ/q ƚÛēÐĢÞ
ŤŕŠńŘťŭŞŒŦőŀ űŰŭŶűŨűŴŬŧŨŀ ŞńťŦŨŴŶŭŪťŭťŦŴŰųťŮŬůŶŭńŀ
ŴŲťůųũŨŲťųŨŀ Ł į ŘťŭŞŒŦńţłƘƧƩăSƆƫƪŅŀ ƅƙĢ
ÞƚǓnjƘſżƓƚ ʼnŇ ÑķƀƨvƪOƂƗĞ�TǕưǛǡ
ǧƮivƉƪǫwźƚƅƫƠƔƘǪÎá³½ÄƘöƉ
ƪ ŘťŭŞŒŦńţŐǪńǵňŎ Ʈ,IJƇƍǫƅƙ ʼn ƑƙƱƳdžǀƳ
ǜƚǪĢÞ¨rƘĬƭƪǞLjǧǕ�ƘL½Ʈ�ƏǪŬůŀ
ŵŬŴŲŰ ƔƙĢÞ¨rƁƟƕƯƖ��ƔƂƗżǪƿǖǕưǛǡ
ǧƘ_ƉƪǫwźƚǪŀ şńƼǡƾǁǍEÛĨǪſƧƜƌƙ
5vĢÞƙ�ƘëƘſƄƪ�êĂ�ƮÆÄƕƇƓǪ
ƙƧŽƗċĶƘ0ƩàƯƔżƪǫŀ ŀ
ň ł ŀŘť ŭŞŒŦńţňŎ ƙ�êĂ�ŀ
ŀ wźƚŀ ŘťŭŞŒŦńţňŎ ƁǪv�ƙëƘſżƓƚªļƥ
ĀeŃŀ ]ëƙÎáßéƘhƃöƇǪÎá *ƘĬƭ
ƪƅƕǪƠƍƗGĺßéƮºżƍXĽƔƚ ŘťŭŞŒŦńţňŎ
ƁƶǥǍƿƳnjǧǁǃáĒƮČ×ƇƓżƪ2êrƤþżƎ
Ƈƍǫŀ�dfƚǪŘťŭŞŒŦńţňŎ ƙĞ�T��ǚƴǃƮ�
üƇƓƌƙ�êƮĂ�Ƈƍǫŀ
ǭł ŀ DžǖǠǕƲljǁǟƮºżƍ ŘťŭŞŒŦńţ ǕưǛǡǧƙŀ
ŀ ŀ �êĂ�ŀ
ŀ ĢÞ¨rƁ��ƔƂƊ¸*VÄƗĂ�ƁAijƗƿǖ
ǕưǛǡǧƮ�ƗLJǧƽljnjƇƓǪDžǖǠǕƲljǁǟƮºżƓ
öĂ�ǪſƧƜ�êĭYXĽƮ÷ƐƓƂƍǫ�df
ƚǪƽǐǜãı|øƔŻƪ ţŒŜŖŞ ¦ƥ ŔšŚŢŠšņŔťų ǁ
ǃNJǜƮºżƓǪL½��üƮćơƍǫŀ
Ǯǩŀ ŠňŐèrìÂßéƮºżƍ�ÿÎá *ǞNjŀ
ŀŀ ŀ ŀǢƙËÔŀ
ŀ Îáßéƙ�êƥ *ƙĂ�ÖƘºżƨƫƪǪN
*êƮ�Ɖƪǚƴǃèrì¼� ŠňŐ ßéƚǪǣLjǐƳ
ǥģUB�Ɣ©ĜGĺƉƪƅƕƔǪÎáǪſƧƜƼǡƱ
ßéƝƕ *ƉƪǫƇƀƇƅƙ�¦ƔƚǪĴÎáÜßé
ƁK£ƉƪƅƕǪv±ƇƍÎáßéƝƙ *Ƙĩ�ī
ƙGĺƁpýƔŻƪÖƙ=Ķ¯ƁŻƐƍǫwźƚǪ�È
GĺÜƘÎá *ƘĬƭƪ@TƮ&žƓGĺƉƪƅƕ
ƔǪŠňŐ ßéƮÉ�īƔ(µƧƃÎáßéƝƕ *ƆƋ
ƪ�Ƙv%Ƈƍǫŀ
ǯǩƌƙƙşńƼǡƾǁǍEÛĨƙ�êĂ�ŀ
ŀ ŀ ǜLjǥEÛĨƙĂ�Ƙ&žƓǪwźƚßéMƔö
Ɖƪ�ÿ şńƼǡƾǁǍEÛĨƙ�êƮǪDžǖǠǕƲljǁǟ
ƮºżƓČƞƍǫŀ
ŀ
86���4�� �!
ňł ŀŘť ŭŞŒŦńţňŎ Ğ�T��ǚƴǃƙĂ�ŀ
ŀ wźƚ ŘťŭŞŒŦńţňŎ ƙ�êĂ�ƙƍƣŃŘťŭŞŒŦńţňŎ
Ğ�T��ǚƴǃƮ�üƇƍǫƅƙĞ�T��ǚƴǃƚ
�Ĥ^ƙÁ´ƮÌƇŃŀ ĥ¸Eǚƴǃƕ¥ĔƇƓ�ĸ
ĦƁ^ƇƓżƍǫƅƙĞ�TƙöĵFƙĈßƗĂ
�Ʈ÷ƐƍƕƅƬŃĄuƮ4ƪªļƥz��ĵFƘhż
öƁĉƣƨƫƍƘŃ®í��ƕƇƓ�ƃĀe�ğƙ
í���ƔöƇƓżƍŀ ŁŗŬŪŅŀ ňłŀ ǫƅƫƨƙâ�ƀ
ƨŃŘťŭŞŒŦńţňŎ Ɓ®í��ƘſżƓ�ĸ÷)Ʈ¡Ƙ#
oƇƓżƪƅƕƁÌ<Ɔƫƍǫŀ
ʼnł ŀţŒŜŖŞŃŀŔšŚŢŠšņŔťų ǁǃNJǜƮºżƍDžǖǠǕŀ
ŀ ŀ Ʋljǁǟ ŘťŭŞŒŦńţ ǕưǛǡǧL½�ƙ�üŀ
ŀ wźƁƅƫƠƔƘ,IJǦ6WƇƍDžǖǠǕƲljǁǟ
ŘťŭŞŒŦńţ ƱƳdžǀƳǜƙŽƏƔŃŀ ³Ƙƌƙ�êƁ ƀƐ
ƓżƗż ŘťŭŞŒŦńţ ƘƑżƓŃŀ ƽǐǜãı|øƔŻƪ
!
! Fig. 1
ţŒŜŖŞ ¦ƥ ŔšŚŢŠšņŔťų ǁǃNJǜƮºżƓǪƌƙL½
��üƮćơƍǫƅƫƠƔƘ ŘťŭŞŒŦńţŐ ƥńţňŏ Ƙ[Ɖ
ƪ ţŒŜŖŞ ǘƻLJǧǪŔšŚŢŠš ǘƻLJǧƮ�ØƇǪDžǖǠǕ
Ʋljǁǟ1Ú-Ƙ�ĝrƘöƆƋƍƕƅƬǪ�Äġ!
ƘL½Ʈ\�ƉƪƅƕƘv%ƇƓżƪǫŀ
Ŋǩŀ ŠňŐ èrìÂßéƮºżƍ�ÿÎá *ǞNjŀ
ŀ ŀ ǢƙËÔŀ
ŀ ŀ ŠňŐ ßéƙm�ƙ *�¦ƚǪǣLjǐƳǥģUB�
Ɣ©ĜGĺƇǪßé�ıIƮivƆƋƪ�¦Ɓºżƨ
ƫƓƂƍǫƇƀƇƅƙ�¦ƔƚǪĴÎáÜßéƁK£Ɖ
ƪƅƕǪv±ƇƍÎáßéƝƙ *Ƙĩ�īƙGĺƁ
pýƔŻƪÖƙ=Ķ¯ƁŻƐƍǫwźƚǪ©ĜGĺƁĴ
ÎáßéƙK£ƙ.@ƕæžǪ�ÈGĺƮH�ƕƇƍ
É�īƔ(µƙðżÎáßé *ÜƮËÔƇƍǫƅƫ
ƠƔƙÎáßé *ƘĬƭƪ@TƙÊÒƘHƒƂǪŁŬłŀ
ǠǛǏǥƮƾǧnjƇƍGĺÅ�Ɣ,`GĺƉƪǪŁŬŬłŀ Ƴǥ
ǃǡǥƥnjǠǥǃǕƵǡǥÖƙÎá *@TƮ8Ƣ°ö¬
GCƮºżƪǪŁŬŬŬłŀ ǣLjǐƳǥģƘ&žƓǪǐljLjǁƼǎ
ǢĭY$ƔŻƪ ŕŒŠţ Ʈ«&ƉƪǪŁŬŵłŀ *ƙ"�¤
İƘ ŗŘŗŏ Ʈ«&ƉƪÖƙ��ƮƕƩ�ƫƍǫƌƙâ�Ǫ
*Ċ\ĪQk Ŋ�ŋ �ÆƘÎáÓđƙivǪō �Æ
ƘƚƧƩ¨ÃƗÓđ�gƁāZƆƫƍǫ�¿�ñƥƸǢ
ǁƴǜƳǝǧǂǥƼƗƖƘƧƪĂ�ƘƧƩǪō �ÆƔïj
ÄƗÎá¨)Ʈ�Ƈƍv±ÎáßéƝƙ *Ɓĉƣƨ
ƫƪ��ƔǪƼǡƱßéƚUBƇƗƀƐƍǫ �ƧƩǪ�
Ƈż�¦ƔƚǪŠňŐ ßéƚm�ƙÝ+ �ƙ�īƔǪ
(µƧƃÎáßéƘƙơ *ƉƪƅƕƁ�ƨƀƕƗƐƍǫŀ
ǯǩƌƙƙşńƼǡƾǁǍEÛĨƙ�êĂ�ŀ
ŀ ßéMƔöƉƪ�ÿ şńƼǡƾǁǍEÛĨƙ�êƮǪ
DžǖǠǕƲljǁǟƮºżƓČƞƍǫwźƚƅƙÛĨ�Ěƙ
5vƘĬƭƪÛēÐĢÞƁ"�èƘſżƓëƘhƃÃ
¶ƉƪƅƕƮþżƎƇƍǫƠƍǪ�ĢÞƙöƮ}#Ɖƪ
ƕǪëƘſżƓit½cƮ¸ƈƪƙƘ[ƇǪƙàäƔ
ƙù¶EƙL*ƚāZƆƫƗƀƐƍǫƅƙ�ƀƨǪƅƙ
ĢÞƁ�ƘëƘſżƓ�êƉƪ�ƁÌ<Ɔƫƍǫŀ
ŀ
�Research projects and annual reports We have been investigating roles of O-linked sugar chains with the linkage structures, GalNAcα1→Ser(Thr), Manα1→Ser(Thr), or GlcNAcβ1→Ser(Thr). O-GalNAc-type sugar chains are called mucin-type carbohydrates and their biosynthesis is initiated by a group of enzymes, UDP-GalNAc: polypeptide N-acetyl- galactosaminyltransferases (GalNAc-Ts). GalNAc-Ts consist of a large gene family with 20 isozymes in humans. Interestingly, GalNAc-T8, -T9, -T17, and
-T18 are catalytically inactive, while GalNAc-T9 and -T17, which were identified by us, are brain-specific and biologically important for the neural differentiation. Based on these backgrounds, we have focused on the functions of glycosyltransferases to make O-glycan carbohydrate-linkage structures, and obtained the following findings. 1) Analysis of mice defective of a GalNAc-T17 gene We found that GalNAc-T17 KO mice showed decreased body weight compared with wild-type mice (Fig. 1). Analysis of GalNAc-T17 expression demonstrated that it was expressed not only in hippocampus and amygdala, but in ventromedial nucleus of hypothalamus, which is known as satiety center. GalNAc-T17 may therefore positively regulate feeding behavior. 2) Production of zebrafish GalNAc-T mutants To produce zebrafish mutants defective of GalNAc-T genes, we employed recently developed genome-editing technology, TALEN and CRISPR/Cas systems. We found that mutations were successfully introduced at the target sites in the zebrafish embryos using TALEN and CRISPR/Cas vectors for GalNAc-T9 and -T18. 3) A rapid and efficient method for neuronal induction of P19 embryonic carcinoma cell line We revised a novel method to efficiently differentiate P19 cells into neurons by an adherent culture in laminin-coated dish in the presence of several reagents to induce neural differentiation and suppress growth of non-neural cells. The new method induced neurons within 4 days without gliogenesis. The mature neurons obtained were responsive to several neurotransmitters with functional neuronal networks. 4) Analysis of extracellular O-glycosylation We investigated the function of a glycosyltransferase in zebrafish, which catalyzes extracellular novel O-glycosylation. We found that it was strongly expressed in the brain of zebrafish embryos, and its suppression caused alterations in the brain development. 96��5��32!
Y. Nakayama, A. Wada, R. Inoue, K. Terasawa, I. Kimura, N.
Nakamura, A. Kurosaka: A Rapid and Efficient Method for
Neuronal Induction of the P19 Embryonic Carcinoma Cell Line.
Journal of Neuroscience Methods, in press.
M. Ogawa, N. Nakamura, Y. Nakayama, A. Kurosaka, H. Manya,
M. Kanagawa, T. Endo, K. Furukawa, T. Okajima: GTDC2
modifies O-mannosylated ŷ-dystroglycan in the endoplasmic
reticulum to generate N-acetyl-glucosamine epitopes reactive
with CTD110.6 antibody. (2013) Biochem Biophys Res
Commun 440(1), 88-93
I. Kimura, Y. Nakayama, Y. Zhao, M. Konishi, N. Itoh:
Neurotrophic effects of neudesine in the central nervous system.
(2013) Front Neurosci 7 (article111), 1-5
Y. Nakayama, N. Nakamura, D. Tsuji, K. Itoh, A. Kurosaka:
Genetic diseases associated with protein glycosylation
disorders in mammals. pp. 244-269 in Genetic Disorders,
Maria Puiu (Ed.), ISBN: 978-953-51-08866-3, InTech.
ŀ
:6���32ŀ
�a>�, :»ŻƦơ, ��Ç, ĿD�ǰ P19ǚƴǃèrì
Âßé�ƮºżƍĖęƀƑ(µƙðżÎáĊ\¦ƙËÔ.
Õ36?�� T¸²V�d�ǪÎybǪ2013.12.3-6
Y. Nakayama, K. Kato, N. Nakamura, A. Kurosaka: The roles
of a putative polypeptide GalNAc-transferase/Wbscr17.
International Symposium on Glyco-Neuroscience, Awaji city
(Japan) 2014.1.9-11
ŀ
;614�����!
Ǭǩŀ Mğďħ ¹Vě��6ÊÒǨƳǥLJǧǗǤNJƳǥÍǩŀ
ċĶ7ǰǶDZdzDzǁǃNJǜČ×õƙǃƻǡǧǏǥƼÜƘĬƉƪÊ
Òŀ
ÊÒ�ùçǰĿDŀ �Ǫ0ndfǰřʼnŌ dǨň dǩŀ
ŀ
VøÊÒ'vHħ'vħǦ�xÄôòÊÒŀ
ċĶ7ǰǞNjǢ¸²Ʈ¨ºƇƍ�PrëÀsĬěƷǧǕưǥ
ÛēÐĢÞƙ�êĂ�ŀ
ÊÒ ~çǰĿDŀ �Ńŀ 0ndfǰřʼnŌńʼnō dŀ Łʼn dłŀ
ŀ
ÏVÊÒĎû'ħǦ�VøĵFǪÎáÛĨ¸²Vŀ
ċĶ7ǰÎá?ĒivƘſƄƪǜLjǥEÛĨƘƧƪ�ƍƗî
ĕĘ#oǁǃNJǜƙĂ�ŀ
ÊÒ�ùçǰ�a>�Ńŀ 0ndfǰřʼnŋńʼnŌ dŀ Łʼn dłŀ
ŀ
VøÊÒ'vHħ'vħǦó{ÊÒŁœłŀ
ċĶ7ǰ��ĺ·J�ƙìÂßéƘſƄƪǚƻǤǔǐƿƳnjǧ
ǁǃƙ�êĂ�ŀ
ÊÒ�ùçǰ�a>�Ńŀ 0ndfǰřʼnŌńʼnō dŀ Łʼn dłŀ
ŀ
ǭǩŀ VM¨)ŀ ŀ
ĿDŀ �ǰ��¸*V�Ćč;Ǫ��õV�ė¾�ğR;ŀ
ŀ
Ǯǩŀ ƌƙŀ
ĿDŀ �ǰśŢŤ ƿƳƶǥǃƾǧǃǨ�Ġ¹�OVĮ_ľ�¸l
Ƙ ŘŗŠ ƙöƕÚüXĽƮ÷ƐƍǫǩǨʼnŇňŊŅŎŅʼnōǩǫŀ
ŀ
ŀ
ǠǙǝǥǑǧŀ ňŌ 3ĻúƘƓŀ